Reach Us +44-1753390542
JC Polyomavirus Infections in Transplant Patients | OMICS International | Abstract
ISSN: 2161-0991

Journal of Transplantation Technologies & Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


JC Polyomavirus Infections in Transplant Patients

Serena Delbue1 and Mariano Ferraresso2,3*

1Laboratory of Translational Research, Health Science Foundation “Ettore Sansavini”, Corso Garibaldi, 11 - 48022 Lugo (RA), Italy

2Department of Clinical Sciences and Community Health, Via F. Sforza 35, University of Milano, 20122, Milano, Italy

3Division of General and Vascular Surgery, St. Joseph Hospital-IRCCS-Multimedia, Via San Vittore 12, 20122, Milano, Italy

*Corresponding Author:
Mariano Ferraresso
Department of General and Vascular Surgery
St. Joseph Hospital-IRCCS-Multimedia
Via San Vittore 12, 20122 Milan, Italy
Fax: +39 0250320394
Tel: +39 0250320382
E-mail: [email protected]

Received Date: October 01, 2012; Accepted Date: October 04, 2012; Published Date: October 12, 2012

Citation: Delbue S, Ferraresso M (2012) JC Polyomavirus Infections in Transplant Patients. J Transplant Technol Res 2: e114. doi: 10.4172/2161-0991.1000e114

Copyright: © 2012 Delbue S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


The polyomavirus JC virus (JCV) is a small nonenveloped DNA virus that asymptomatically infects about 80% of healthy adults and establishes latency in the kidney tissue. In case of immunodeficient hosts, JCV can lytically infect the oligodendrocytes, causing a fatal demyelinating disease, known as Progressive Multifocal Leukoencephalopathy (PML). Although the reactivation of another human polyomavirus, BK Virus (BKV), is relatively common and its association with the Polyomavirus Associated Nephropathy (PVAN) following renal transplantation is assessed, JCV replication and its impact on graft function and survival is less well studied. In addition, none of the performed studies
ruled out the hypothesis that JCV could be associated with certain post-transplantation clinical syndromes. Thus, monitoring of Polyomaviruses infection, especially during the first 24 months post-transplantation, is recommended.